MENTOR MEMORYSHAPE BREAST IMPLANTS
Mentor Worldwide, LLC · Decision date Jun 14, 2013
What did the FDA approve?
FDA approved the Mentor MemoryShape Breast Implants on June 14, 2013. The approval covers females for breast augmentation in women at least 22 years old, including primary augmentation to increase breast size and revision surgery to correct or improve a prior primary augmentation result.
The approval also covers breast reconstruction, including primary reconstruction to replace breast tissue removed due to cancer or trauma or that failed to develop properly due to a severe breast abnormality, and revision surgery to correct or improve a prior primary reconstruction result. The device is a noninflatable, internal, silicone gel-filled breast prosthesis.
FDA approval order statement
APPROVAL FOR THEMEMORYSHAPE BREAST IMPLANTS. THIS DEVICE IS INDICATED FOR FEMALES FOR THE FOLLOWING USES(PROCEDURES):1) BREAST AUGMENTATION FOR WOMEN AT LEAST 22 YEARS OLD. BREAST AUGMENTATION INCLUDES PRIMARYBREAST AUGMENTATION TO INCREASE THE BREAST SIZE, AS WELL AS REVISION SURGERY TO CORRECT OR IMPROVE THE RESULT OF A PRIMARY BREAST AUGMENTATION SURGERY. 2) BREAST RECONSTRUCTION. BREAST RECONSTRUCTION INCLUDES PRIMARY RECONSTRUCTION TO REPLACEBREAST TISSUE THAT HAS BEEN REMOVED DUE TO CANCER OR TRAUMA OR THAT HAS FAILED TO DEVELOP PROPERLY DUE TO A SEVERE BREAST ABNORMALITY. BREAST RECONSTRUCTION ALSO INCLUDES REVISIONSURGERY TO CORRECT OR IMPROVE THE RESULTS OF A PRIMARY BREAST RECONSTRUCTION SURGERY.
- Regulatory pathway
- Original PMA
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Jun 14, 2013
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P060028
- Regulatory pathway
- Premarket approval application
- Applicant
- Mentor Worldwide, LLC
- Product code
- FTR
- Decision code
- APPR
- Decision date
- Jun 14, 2013
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.
- Applicant
- Mentor Worldwide, LLC
- Product code
- FTR
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P060028 received
Application receipt date recorded by FDA.
P060028 · FDA decision
APPR
P060028/S063 · Related supplement
MemoryShape Breast Implants
Timeline entries are records held by MedtechLedger for P060028. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060028
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MemoryShape Breast ImplantsP060028/S063 | Mentor Worldwide, LLC | PMA supplement | Oct 23, 2026 | FDA |
Explore the linked device profile
Other records with product code FTR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Sientra Silicone Gel Breast ImplantsP070004/S049 | Tiger Aesthetics Medical, LLC | PMA supplement | Nov 4, 2026 | FDA |
MemoryGel Breast ImplantsP030053/S093 | Mentor Corp. | PMA supplement | Oct 23, 2026 | FDA |
| Motiva USA, LLC | PMA supplement | Oct 2, 2026 | FDA | |
| Allergan | PMA supplement | Sep 29, 2026 | FDA | |
| Motiva USA, LLC | PMA supplement | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Mentor Worldwide, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 33 Technology Dr., Irvin, CA, 92618
Sources and methodology
- Original FDA record: P060028
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



